• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
STW
Click for more information
0.94% $76.02

SPDR S&P/ASX 200 FUND - Charts / Financials

Market Cap $5.660B  ! watchlist Created with Sketch. Add to my watchlist
refresh Created with Sketch. REFRESH
Last update - 15.57pm 22/11/2024 (20 minute delay) ?
Day
Open $75.85   Day High $76.21   Day Low $75.83
Daily Volume 53947
Bids   Sellers
Number Price Volume   Number Price Volume
0 $75.99 2000   0 $76.03 7348

Data source: Refinitiv

(20min delay)
Last
$76.02 		Change
0.710(0.94%) 		Mkt cap ! $5.660B
Open High Low Value Volume
$75.85 $76.21 $75.83 $4.092M 53.94K

Buyers (Bids)

No. Vol. Price($)
0 2000 $75.99
 

Sellers (Offers)

Price($) Vol. No.
$76.03 7348 0
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
Last
$76.09 		  Change
0.710 ( 1.09 %)
Open High Low Volume
$75.86 $76.20 $75.86 13476
Last updated 15.57pm 22/11/2024 ?

Top Stories

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game  Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.